ANANDA LABS
THANK YOU FOR SUBMITTING YOUR CONTACT INFORMATION
We will contact you shortly.
Your contact details are fully submitted and transfered to the relevant deparment for further processing.
Mealwhile- You are more than welcome to check out the vat possibilities, scientific opportunities, medical breakthoughs, here, at the bottom of the page.
Our technology has been shown to:
Reset the epigenetic age of elderly skin cells
Ananda Labs is developing a novel approach to reverse aging using epigenetic reprogramming. The company claims that its method can reset the epigenetic age of skin cells back to a younger state, as supported by independent assessments conducted by CLOCK FOUNDATION
Improve cell migration and myofibroblast production
Ananda Labs’ rejuvenation protocol, using “Buganim proteins,” has been shown to improve cell migration and increase myofibroblast production in elderly skin cells
Restore DNA
compaction
Revolutionizing Healthcare and Skincare:
Ananda Labs is committed to translating cutting-edge science into real-world solutions. Our initial product pipeline focuses on three key areas:
The business model behind Ananda Labs
Ananda Labs is committed to translating cutting-edge science into real-world solutions. Our initial product pipeline focuses on three key areas:
- Skincare: Rejuvenated fibroblast injections to revitalize aging skin
- Age-related macular degeneration (AMD) treatment: Innovative gene therapy approaches targeting retinal cells
- Immune system improvement: Enhancement of immune stem cell function
Why Invest in Ananda Labs?
- We offer a paradigm shift in anti-aging therapy, moving beyond symptom management to address the root causes of aging at the cellular level.
- Our technology is backed by robust scientific evidence and a commitment to safety, surpassing the limitations of existing approaches.
- We have a clear vision for product development, with a focus on high-impact areas with significant market potential.
- We are actively collaborating with leading physicians and institutions, ensuring clinical relevance and accelerating the translation of our research.
